弥漫大B细胞淋巴瘤中期PET中Deauville 4-5分病灶自动代谢肿瘤体积测量的观察者间一致性
该研究评估了45例中期18F-FDG PET扫描中60个Deauville 4-5分弥漫大B细胞淋巴瘤病灶,比较6种半自动分割方法。MV3(至少3种方法共识)表现最佳,90%病灶获可接受勾画且阳性一致率93%;勾画方法偏好强烈依赖病灶SUVmax,SUVmax<10时MV3最佳,>10时SUV4.0更优。
要点
- MV3在中期PET的Deauville 4-5分病灶中提供最高观察者间一致性。
- 勾画质量与方法偏好强烈依赖病灶SUVmax,低与高SUVmax病灶适用不同方法。
- 按SUVmax分类选择最优方法可改善整体勾画质量和阳性一致率。
核心结论
- 在中期PET上,MV3表现最佳,对Deauville 4-5分弥漫大B细胞淋巴瘤病灶的可接受勾画提供最高观察者间一致性。
- 勾画方法偏好强烈依赖病灶SUV,建议探索根据肿瘤18F-FDG摄取特征(即SUVmax)为每个病灶识别最佳勾画方法。
研究设计与样本
- 研究纳入45例中期18F-FDG PET扫描中的Deauville 4-5分病灶,共60个病灶。
- 使用6种半自动分割方法进行勾画,由3名独立观察者将每个MTV的勾画质量评为可接受或不可接受。
- 评估每种方法的观察者勾画质量评分、特异性一致性和MTV,并按病灶SUVmax(<5、5-10、>10)分类分析。
主要发现
- 在60个Deauville 4-5分病灶中,MV3表现最佳,90%病灶勾画可接受,阳性一致率为93%。
- 各方法的勾画质量评分和一致性强烈依赖病灶SUV:SUVmax<10的病灶使用MV3获得最佳勾画质量评分,更高18F-FDG亲和力的病灶使用SUV4.0更优。
- 应用按SUV分类的最优选方法替代单一MV3方法后,整体勾画质量和阳性一致率改善。
- SUVmax>10的病灶中,排除视觉上失败的MV3勾画后,MV3与SUV4.0得出的MTV相当。
- SUVmax<10的病灶中,不同方法得出的MTV相关性差。
关键数值与推荐
- MV3在60个Deauville 4-5分病灶中勾画可接受率为90%,阳性一致率为93%。
临床怎么用
- 中期PET的MTV勾画可优先考虑MV3以获得最高观察者间一致性,但需根据病灶SUVmax调整方法。
- 对SUVmax<10的病灶可选用MV3,对更高18F-FDG亲和力病灶可选用SUV4.0以优化勾画质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Metabolic tumor volume (MTV) on interim PET (I-PET) is a potential prognostic biomarker for diffuse large B-cell lymphoma (DLBCL). Implementation of MTV on I-PET requires a consensus on which semiautomated segmentation method delineates lesions most successfully with least user interaction. Methods used for baseline PET are not necessarily optimal for I-PET because of lower lesional SUVs at I-PET. Therefore, we aimed to evaluate which method provides the best delineation quality for Deauville score (DS) 4-5 DLBCL lesions on I-PET at the best interobserver agreement on delineation quality and, second, to assess the effect of lesional SUVmax on delineation quality and performance agreement. Methods: DS 4-5 lesions from 45 I-PET scans were delineated using 6 semiautomated methods: a fixed SUV threshold of 2.5 g/cm3, a fixed SUV threshold of 4.0 g/cm3, an adaptive threshold corrected for source-to-local background activity contrast at 50% of the SUVpeak, 41% of SUVmax per lesion, a majority vote including voxels detected by at least 2 methods, and a majority vote including voxels detected by at least 3 methods (MV3). Delineation quality per MTV was rated by 3 independent observers as acceptable or nonacceptable. For each method, observer scores on delineation quality, specific agreement, and MTV were assessed for all lesions and per category of lesional SUVmax (<5, 5-10, >10). Results: In 60 DS 4-5 lesions on I-PET, MV3 performed best, with acceptable delineation in 90% of lesions and a positive agreement of 93%. Delineation quality scores and agreement per method strongly depended on lesional SUV: the best delineation quality scores were obtained using MV3 in lesions with an SUVmax of less than 10 and using SUV4.0 in more 18F-FDG-avid lesions. Consequently, overall delineation quality and positive agreement improved by applying the most preferred method per SUV category instead of using MV3 as the single best method. The MV3- and SUV4.0-derived MTVs of lesions with an SUVmax of more than 10 were comparable after exclusion of visually failed MV3 contouring. For lesions with an SUVmax of less than 10, MTVs using different methods correlated poorly. Conclusion: On I-PET, MV3 performed best and provided the highest interobserver agreement regarding acceptable delineations of DS 4-5 DLBCL lesions. However, delineation-method preference strongly depended on lesional SUV. Therefore, we suggest exploration of an approach that identifies the optimal delineation method per lesion as a function of tumor 18F-FDG uptake characteristics, that is, SUVmax.
引用
- Zwezerijnen GJC, Eertink JJ, Burggraaff CN, et al. Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma. J Nucl Med. 2021. PMID: 33674403. doi:10.2967/jnumed.120.258673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。